UPClytics
View all cases

UPC APP 54214/2024

Oct 1, 2024·EP3056563 · METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL

Case details
Status
Case Closed
Action
Generic
Category
File-access requests (R. 262.1(b))
Parties
Claimants
Representatives
Respondents
Representatives
Division
Munich CD
Technology
  • Chemistry
    Biotechnology · Pharmaceuticals
Language
English
First decided
Nov 4, 2024
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Munich CDLocked
Judge Ulrike VoßLocked
Judge András KupeczLocked
Judge Paolo GerliLocked

At the UPC: Mathys & Squire LLP (0 cases)·ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (4 cases)

This dispute contains 1 other proceedings

UPC APP 588681/2023

4 other defendants litigating the same or a related patent

UPC CFI 75/2023·UPC CFI 80/2023·ORD 464985/2023·ORD 465342/2023

Start a free trial to see how each one ended.

More cases: Munich CD·2024

Decisions
  • 2024-11-04
    Application RoP262 3Public

    Summary: The Central Division (Munich) addressed Mathys & Squire LLP's request for access to pleadings under Rule 262.1(b) RoP in the Astellas v. Healios revocation action, ruling on confidentiality of certain pipeline information following the parties' settlement.

    Show the legal issues (3)
    • Public access to pleadings Rule 262.1(b) RoP
    • Confidentiality Rule 262.2 RoP
    • Trade secrets
Document titleDatePublic
Final Order anonymised2024-11-05Not public
Headnote-and-Keywords2024-11-04Not public
Outcome of the Order2024-11-04Not public
final order 262.32024-11-04Public
final order 262.32024-11-04Not public
Template-Order2024-11-04Not public
Letter to the Court2024-10-18Not public
preliminary order2024-10-08Not public
Receipt2024-10-02Not public
Formal-checks_Notification-of-positive-outcome2024-10-02Not public